Jennifer Schneider
CIK 1783060 · President · last filed 2026-05-05
Jennifer Schneider is a President who has filed 20 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing, for VRTX, was dated May 5, 2026. Across all open-market trades the lifetime net is −$14.2M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.1M across reported positions. 4 SEC filings were submitted jointly with VERTEX PHARMACEUTICALS INC / MA.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LVGO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
150 WEST EVELYN AVENUE, SUITE 150
MOUNTAIN VIEW, CA 94041
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VRTX | Director | 2,190 | $510.08 | $1.12M | $0 | 3 | 2026-05-05 |
| Livongo Health, Inc. (LVGO) Delisted | President | 0 | — | — | -$14.22M | 17 | 2020-10-30 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-05 | VRTX | Mixed | −324 | $0 | EDGAR |
| 2025-05-05 | VRTX | Grant (A) | +796 | $0 | EDGAR |
| 2024-05-17 | VRTX | Grant (A) | +922 | $0 | EDGAR |
| 2020-10-30 | Livongo Health, Inc. (LVGO) Delisted | Disp (D) | −208,387 | $0 | EDGAR |
| 2020-09-04 | Livongo Health, Inc. (LVGO) Delisted | Mixed | — | -$7.45M | EDGAR |
| 2020-08-28 | Livongo Health, Inc. (LVGO) Delisted | Sell (S) | −8,598 | -$1.14M | EDGAR |
| 2020-08-05 | Livongo Health, Inc. (LVGO) Delisted | Mixed | — | -$1.82M | EDGAR |
| 2020-07-06 | Livongo Health, Inc. (LVGO) Delisted | Mixed | −1,576 | -$986.2K | EDGAR |
| 2020-06-03 | Livongo Health, Inc. (LVGO) Delisted | Mixed | −5,409 | -$779.1K | EDGAR |
| 2020-05-28 | Livongo Health, Inc. (LVGO) Delisted | Tax (F) | −6,354 | -$349.5K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.